These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22645426)

  • 21. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.
    Kuo HC; Yang KD; Juo SH; Liang CD; Chen WC; Wang YS; Lee CH; Hsi E; Yu HR; Woon PY; Lin IC; Huang CF; Hwang DY; Lee CP; Lin LY; Chang WP; Chang WC
    PLoS One; 2011 Apr; 6(4):e17370. PubMed ID: 21533171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-nucleotide Polymorphism rs17860041 A/C in the Promoter of the
    Shi R; Luo Y; Li S; Kong M; Liu X; Yu M; Wu J; Huang L; Yang Z
    Immunol Invest; 2021 Feb; 50(2-3):230-242. PubMed ID: 32079425
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions.
    Sheu JJ; Lin YJ; Chang JS; Wan L; Chen SY; Huang YC; Chan C; Chiu IW; Tsai FJ
    Int J Immunogenet; 2010 Dec; 37(6):487-92. PubMed ID: 20618517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of CD40 SNPs with Moyamoya in a Chinese children population.
    Shen W; Liao Y; Garcia R; Kesavabhotla K; Xu B; Li H
    Br J Neurosurg; 2019 Aug; 33(4):398-401. PubMed ID: 30681383
    [No Abstract]   [Full Text] [Related]  

  • 25. The
    Fu LY; Qiu X; Deng QL; Huang P; Pi L; Xu Y; Che D; Zhou H; Lu Z; Tan Y; Jiang Z; Zhang L; Liu T; Gu X
    J Immunol Res; 2019; 2019():4730507. PubMed ID: 31093510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children.
    Huang FY; Chang TY; Chen MR; Hsu CH; Lee HC; Lin SP; Kao HA; Chiu NC; Chi H; Liu TY; Liu HF; Dang CW; Chu CC; Lin M; Sung TC; Lee YJ
    Hum Immunol; 2007 Jan; 68(1):69-74. PubMed ID: 17207714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between E148Q MEFV variant and Kawasaki disease.
    Yamaguchi K; Ikeda K; Ihara K; Takada H; Kusuhara K; Hara T
    Hum Immunol; 2009 Jun; 70(6):468-71. PubMed ID: 19026701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
    Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
    Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin α2 gene polymorphism is a risk factor of coronary artery lesions in Chinese children with Kawasaki disease.
    Yuan J; Jiang Z; Li M; Li W; Gu X; Wang Z; Pi L; Xu Y; Zhou H; Zhang B; Deng Q; Wang Y; Huang P; Zhang L; Gu X
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):12. PubMed ID: 33557870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
    Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
    Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
    Tang B; Lo HH; Lei C; U KI; Hsiao WW; Guo X; Bai J; Wong VK; Law BY
    Phytomedicine; 2020 Apr; 70():153208. PubMed ID: 32283413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions.
    Kuo HC; Chang JC; Guo MM; Hsieh KS; Yeter D; Li SC; Yang KD
    PLoS One; 2015; 10(11):e0143056. PubMed ID: 26619243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human lymphocyte antigen B-associated transcript 2, 3, and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm.
    Hsieh YY; Lin YJ; Chang CC; Chen DY; Hsu CM; Wang YK; Hsu KH; Tsai FJ
    J Clin Lab Anal; 2010; 24(4):262-8. PubMed ID: 20626023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.
    Furuno K; Takada H; Yamamoto K; Ikeda K; Ohno T; Khajoee V; Mizuno Y; Hara T
    J Pediatr; 2007 Aug; 151(2):155-60, 160.e1. PubMed ID: 17643768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.
    Huang YH; Hsu YW; Lu HF; Wong HS; Yu HR; Kuo HC; Huang FC; Chang WC; Kuo HC
    Medicine (Baltimore); 2016 Apr; 95(17):e3501. PubMed ID: 27124053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan.
    Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai YH; Tsai CH; Tsai FJ
    J Rheumatol; 2008 Jul; 35(7):1408-13. PubMed ID: 18484687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.
    Kuo HC; Hsu YW; Wu CM; Chen SH; Hung KS; Chang WP; Yang KD; Hsieh KS; Chen WC; Onouchi Y; Chang WC
    PLoS One; 2013; 8(7):e69685. PubMed ID: 23894522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A LncRNA gene polymorphism (rs1814343) is associated with the risk of coronary artery lesions in southern Chinese Kawasaki disease patients.
    Chen W; Chen S; Tian Y; Liu Y; Chen C; Wang B; Chen C; Liu F
    J Gene Med; 2023 Aug; 25(8):e3514. PubMed ID: 37097087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children.
    Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai FJ
    Eur J Pediatr; 2010 Jun; 169(6):713-9. PubMed ID: 19882345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.